The oxidative stress assay market is projected to reach USD 1,326 million by 2025 from USD 836 million in 2020, at a CAGR of 9.7%. Growth in the oxidative stress assay market can be attributed to growth in the biopharmaceutical industry and increasing public-sector funding for academic research. Other important factors aiding the growth of this market include technological advancements like HCS for drug discovery, increasing R&D expenditure in biotechnology and pharmaceutical industries, and government support for pharmaceutical and biotechnology industries. On the other hand, the high cost of instruments and shortage of trained and qualified personnel are the major factors restraining the growth of this market.
The consumables segment accounted for the largest market share in 2020. Based on products, the oxidative stress assay market is segmented into consumables, instruments, and software and services.Consumables is the largest and fastest-growing segment in 2020.
This large share and high growth can be attributed the recurring requirement of consumables as compared to instruments which is the key factor driving the growth of this segment.
The cardiovascular diseases segment will continue to dominate the oxidative stress assay market during the forecast period. Based on disease type, the oxidative stress assays market is segmented into cardiovascular diseases, diabetes, cancer, respiratory diseases, and other diseases. The cardiovascular diseases segment accounted for the largest share of this market in 2020, primarily due to the high and growing prevalence of cardiovascular diseases across the globe.
The oxidative stress assay market in the Asia Pacific region is expected to witness the highest growth rate during the forecast period. Geographically, the oxidative stress assay market is segmented into North America, Europe, Asia Pacific, and Rest of the World.The Asia Pacific market is expected to grow at the highest CAGR during the forecast period, primarily due to the reason that the Asia Pacific oxidative stress assays market offers significant growth opportunities for market players to expand their presence in this region.
Emerging markets such as China and India are witnessing growth due to the large patient population and increasing healthcare expenditure. This has resulted in the increasing acceptance of advanced technologies, such as oxidative stress assays, in the Asia Pacific region.
Breakdown of supply-side primary interviews: • By Company Type: Tier 1: 55%, Tier 2: 20%, and Tier 3: 25% • By Designation: C-level: 35%, Director-level: 25%, and Others: 40% • By Region: North America - 20%, Europe – 25%, APAC – 40%, Rest of the World– 15%
The prominent players in this market are Abcam, plc (UK), Enzo Biochem, Inc. (US), Merck KGaA (Germany), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), AMS Biotechnology (Europe), Ltd. (UK), BioVision, Inc. (US), Cell Biolabs, Inc. (US), Oxford Biomedical Research (US), Promega Corporation (US), Cayman Chemical (US), Eagle Biosciences, Inc. (US), Arbor Assays (US), Hycult Biotech (Netherlands), Callegari SRL (Italy), Kamiya Biomedical Company (US), MEGA TIP San.Tic.Ltd.Sti. (Turkey), ImmunoChemistry Technologies, LLC (US), Genox Corporation (US), and Toxys B.V. (Netherlands).
Research Coverage • The report studies the oxidative stress assay market based on test type, technology, disease type, product, end user and region • The report analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth • The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders • The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total oxidative stress assay market • The report forecasts the revenue of market segments with respect to four major regions
Reasons to Buy the Report:
The report provides insights on the following pointers: • Market Penetration: Comprehensive information on the oxidative stress assay offered by the key 20 players in the oxidative stress assay market. The report analyzes the oxidative stress assay market by test type, technology, disease type, product, end user and region. • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various oxidative stress assay, their adoption, and usage across key geographic regions. • Market Diversification: Exhaustive information about new product launches & approvals, untapped geographies, recent developments, and investments in the oxidative stress assay market • Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the oxidative stress assay market.
Our reports have been used by over 10K customers, including:
The microcarrier market is majorly driven by factors such as rising demand for cell-based vaccines and therapeutics, the rapid growth of biologics and biosimilar industry, and increasing R&D and availability of funding for cell therapy research. Many of the current biologics in the pipeline are targeting the indications, which are small-molecule...
The global cell isolation market size is projected to reach USD 15.0 billion by 2025 from USD 6.9billion in 2020, at a CAGR of 16.8% during the forecast period. Market growth is driven by factors The growing investments in personalized medicine can primarily be attributed to the growing demand for advanced treatments with minimal side-effects...
The protein A resin market is expected to reach USD 1.9 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 11.4% during the forecast period. The protein A resin market has witnessed increasing consumption due to increased monoclonal antibody production on account of the pandemic situation worldwide.. Growth in the market can primarily...
The global recombinant proteins market is projected to reach USD 1.7billion by 2026 from USD 1.0billion in 2021, at a CAGR of 9.8% during the forecast period. The market growth is primarily driven by factors such as increasing government investments and R&D expenditure in pharmaceutical & biotechnology companies, growing industryacademia collaborations,...
The anti-money laundering solution market was valued at US$ 1,503.99 million in 2019 and is projected to reach US$ 5,866.51 million by 2027; it is expected to grow at a CAGR of 16.2% from 2020 to 2027. Transaction monitoring is a crucial procedure and key control in anti-money laundering (AML) and countering the financing of terrorism (AML/CFT)...
The microcarriers market is projected to reach USD 2.9 billion by 2026 from USD 1.7 billion in 2021, at a CAGR of 10.7% during the forecast period. Increasing use of single-use bioreactors for bioprocessing, rising investmnet in R&D for developemnt of vaccines and therapeutic protiens, and increasing government funding for cell and gene therapy. •...
206 pages •
By The Business Research Company
• Dec 2020
Pegfilgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Impact And Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global pegfilgrastim biosimilars market. Description: Where is the largest and fastest growing...
The market for cell culture is driven by factors such as rising demand for vaccines, artificial organs and biopharmaceuticals, and growing focus on personalized medicine. Immunization is the most valuable and cost-effective intervention that delivers better health as well as social and economic benefits. Annually, around 2 to 3 million...
317 pages •
By The Business Research Company
• Oct 2020
Oral Biologics & Biosimilars Global Market Opportunities And Strategies To 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global oral biologics and biosimilars market.
Where is the largest and fastest growing market for the oral...
The increasing number of lyophilized drugs is projected to drive the dual chamber syringes market.
The global dual chamber syringes market size is projected to grow from USD 131 million in 2020 to USD 182 million by 2025, at a compound annual growth rate (CAGR) of 6.8% between 2020 and 2025. The global dual chamber syringes industry has...
Biosimilar Penetration Rate
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.